Parameter
| Biomarker | IL-6 | Full name | Interleukin-6 | Molecular Type | Cytokines |
|---|---|---|---|---|---|
| Molecular Formula | Macromolecule | Molecular Weight | / | Core Functional Dimensions | Study stage, prognosis |
| Disease | Metabolic Syndrome | Disease Subtypes | / | ||
| Organ | Adipose Tissue/Immune Cells | Test Sample / Technology Platform | Serum (ELISA, flow cytometry) | ||
| Pathobiological Mechanisms | Adipose tissue and immune cell secretion, promote insulin resistance and vascular injury | ||||
| Clinical Availability Status | To explore clinical application: used to assess MetS inflammation, associated with the risk of complications | ||||
| Notes and Dynamics | Targeted IL - 6 treatment could improve the metabolic disorder | ||||